Skip to main content
SpringerLink
Log in

Hypertension in End-Stage Renal Disease: Dialysis

Pediatric Hypertension

  • 119 Accesses

Abstract

Hypertension and left ventricular hypertrophy are highly prevalent in the pediatric dialysis population. Ambulatory or home blood pressure monitoring is required to obtain prognostically relevant information about a patient’s blood pressure status. Volume status is the primary determinant of blood pressure in dialysis patients; the clinical relevance of additional pathogenic mechanisms such as sympathetic hyperactivity is controversial. The most important measure to maintain normal blood pressure is achievement of the dry weight, which can be facilitated by the use of bioimpedance analysis and intradialytic blood volume monitoring. Dietary salt restriction and avoidance of net salt uptake during dialysis is key to maintain fluid balance. Extended hemodialysis schedules efficiently normalize blood pressure and reverse left ventricular hypertrophy in patients who cannot maintain fluid balance under standard thrice weekly hemodialysis. Pharmacotherapy of hypertension should only be reserved to patients with persistent hypertension despite adequate volume status. The preferable first-line antihypertensive drug class is currently unclear; head-to-head comparative trials are urgently needed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  • Agarwal R (2010) Blood pressure and mortality among hemodialysis patients. Hypertension 55:762–768

    Google Scholar 

  • Agarwal R, Lewis RR (2001) Prediction of hypertension in chronic hemodialysis patients. Kidney Int 60:1982–1989

    Article  CAS  PubMed  Google Scholar 

  • Agarwal R, Sinha AD (2009) Cardiovascular protection with antihypertensive drugs in dialysis patients in dialysis patients: systematic review and meta-analysis. Hypertension 53:860–866

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Agarwal R, Andersen MJ, Bishu K, Saha C (2006a) Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int 69:900–906

    Article  CAS  PubMed  Google Scholar 

  • Agarwal R, Brim NJ, Mahenthiran J, Andersen MJ, Saha C (2006b) Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension. 47:62–68

    Article  CAS  PubMed  Google Scholar 

  • Agarwal R, Peixoto AJ, Santos SF, Zoccali C (2006c) Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 1:389–398

    Article  PubMed  Google Scholar 

  • Agarwal R, Andersen MJ, Light RP (2008) Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients. Am J Nephrol 28:210–217

    Article  PubMed  Google Scholar 

  • Agarwal R, Bouldin JM, Light RP, Garg A (2011) Inferior vena cava diameter and left atrial diameter measure volume but not dry weight. Clin J Am Soc Nephrol 6:1066–1072

    Article  PubMed  PubMed Central  Google Scholar 

  • Agarwal R, Satyan S, Alborzi P, Light RP, Tegegne GG, Mazengia HS, Yigazu PM (2009) Home blood pressure measurements for managing hypertension in hemodialysis patients. Am J Nephrol 30:126–134

    Article  PubMed  PubMed Central  Google Scholar 

  • Alborzi P, Patel N, Agarwal R (2007) Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol 2:1228–1234

    Article  PubMed  Google Scholar 

  • Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, Salvador M, Chamontin B (2000) Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int 57:2485–2491

    Article  CAS  PubMed  Google Scholar 

  • Anderstam B, Katzarski K, Bergström J (1997) Serum levels of NO, NG-dimethyl-L-Arginine, a potential endogenous nitic oxide inhibitor in dialysis patients. J Am Soc Nephrol 8:1437–1442

    CAS  PubMed  Google Scholar 

  • Arbor Research Collaborative for Health. The DOPPS Practice Monitor. www.dopps.org/DPM/. Accessed 30 Jan 2017.

  • Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG (2002) Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens 20:3–9

    Article  CAS  PubMed  Google Scholar 

  • Bakkaloglu SA, Borzych D, Soo Ha I, Serdaroglu E, Büscher R, Salas P, Patel H, Drozdz D, Vondrak K, Watanabe A, Villagra J, Yavascan O, Valenzuela M, Gipson D, Ng KH, Warady BA, Schaefer F, International Pediatric Peritoneal Dialysis Network (2011) Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry. Clin J Am Soc Nephrol 6:1926–1933

    Article  PubMed  PubMed Central  Google Scholar 

  • Bakris GL, Hart P, Ritz E (2006) Beta blockers in the management of chronic kidney disease. Kidney Int 70:1905–1913

    Article  CAS  PubMed  Google Scholar 

  • Bakris GL, Burkart JM, Weinhandl ED, McCullough PA, Kraus MA (2016) Intensive hemodialysis, blood pressure, and antihypertensive medication use. Am J Kidney Dis 68:S15–S23

    Article  PubMed  Google Scholar 

  • Bansal N, McCulloch CE, Rahman M, Kusek JW, Anderson AH, Xie D, Townsend RR, Lora CM, Wright J, Go AS, Ojo A, Alper A, Lustigova E, Cuevas M, Kallem R, Hsu CY, Study Investigators CRIC (2015) Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study. Hypertension 65:93–100

    Article  CAS  PubMed  Google Scholar 

  • Bayya A, Rubinger D, Linton DM, Sviri S (2011) Evaluation of intradialytic hypotension using impedance cardiography. Int Urol Nephrol 43:855–864

    Article  PubMed  Google Scholar 

  • Bircan Z, Duzova A, Cakar N, Bayazit AK, Elhan A, Tutar E, Ozcakar ZB, Ucar T, Kargin E, Erdem S, Karagöz T, Babaoglu A, Sancak B, Noyan A, Soylemezoglu O, Bakkaloglu A, Yalcinkaya F (2010) Predictors of left ventricular hypertrophy in children on chronic peritoneal dialysis. Pediatr Nephrol 25:1311–1318

    Article  PubMed  Google Scholar 

  • Borzych D, Bakkaloglu SA, Zaritsky J, Suarez A, Wong W, Ranchin B, Qi C, Szabo AJ, Coccia PA, Harambat J, Mitu F, Warady BA, Schaefer F (2011) International Pediatric Peritoneal Dialysis Network. Defining left ventricular hypertrophy in children on peritoneal dialysis. Clin J Am Soc Nephrol 6:1934–1943

    Article  PubMed  PubMed Central  Google Scholar 

  • Borzych-Duzalka D, Bilginer Y, Ha IS, Bak M, Rees L, Cano F, Munarriz RL, Chua A, Pesle S, Emre S, Urzykowska A, Quiroz L, Ruscasso JD, White C, Pape L, Ramela V, Printza N, Vogel A, Kuzmanovska D, Simkova E, Müller-Wiefel DE, Sander A, Warady BA, Schaefer F, International Pediatric Peritoneal Dialysis Network (IPPN) Registry (2013) Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol 24:665–676

    Article  PubMed  PubMed Central  Google Scholar 

  • Candan C, Sever L, Civilibal M, Caliskan S, Arisoy N (2009) Blood volume monitoring to adjust dry weight in hypertensive pediatric hemodialysis patients. Pediatr Nephrol 24:581–587

    Article  PubMed  Google Scholar 

  • Cannella G, Paoletti E, Delfino R, Peloso G, Rolla D, Molinari S (1997) Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis 30:659–664

    Article  CAS  PubMed  Google Scholar 

  • Chaudhuri A, Sutherland SM, Begin B, Salsbery K, McCabe L, Potter D, Alexander SR, Wong CJ (2011) Role of twenty-four-hour ambulatory blood pressure monitoring in children on dialysis. Clin J Am Soc Nephrol 6:870–876

    Article  PubMed  PubMed Central  Google Scholar 

  • Chavers BM, Solid CA, Daniels FX, Chen SC, Collins AJ, Frankenfield DL, Herzog CA (2009) Hypertension in pediatric long-term hemodialysis patients in the United States. Clin J Am Soc Nephrol 4:1363–1369

    Article  PubMed  PubMed Central  Google Scholar 

  • Converse RLJ, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F et al (1992) Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327:1912–1918

    Article  PubMed  Google Scholar 

  • Correa-Rotter R, Cueto-Manzano A (2001) The problem of the high transporter: is survival decreased? Perit Dial Int. 21(Suppl 3):S75–S79

    PubMed  Google Scholar 

  • Drechsler C, Ritz E, Tomaschitz A, Pilz S, Schönfeld S, Blouin K, Bidlingmaier M, Hammer F, Krane V, März W, Allolio B, Fassnacht M, Wanner C (2013) Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients. Eur Heart J 34:578–587

    Article  CAS  PubMed  Google Scholar 

  • Fabian Velasco R, Lagunas Muñoz J, Sanchez Saavedra V, Mena Brito Trejo JE, Qureshi AR, García-López E, Divino Filho JC (2008) Automated peritoneal dialysis as the modality of choice: a single-center, 3-year experience with 458 children in Mexico. Pediatr Nephrol 23:465–471

    Article  PubMed  Google Scholar 

  • Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O'Brien E, Wang J, Staessen JA, International Database on Ambulatory Blood Pressure In Relation to Cardiovascular Outcomes Investigators (2010) Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 28:2036–2045

    Article  CAS  PubMed  Google Scholar 

  • Fischbach M, Terzic J, Laugel V, Dheu C, Menouer S, Helms P, Livolsi A (2004) Daily on-line haemodiafiltration: a pilot trial in children. Nephrol Dial Transplant 19:2360–2367

    Article  PubMed  Google Scholar 

  • Fischbach M, Schmitt CP, Shroff R, Zaloszyc A, Warady BA (2016) Increasing sodium removal on peritoneal dialysis: applying dialysis mechanics to the peritoneal dialysis prescription. Kidney Int 89:761–766

    Article  CAS  PubMed  Google Scholar 

  • Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE (1995) Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 47:186–192

    Article  CAS  PubMed  Google Scholar 

  • Georgianos PI, Agarwal R (2016) Epidemiologiy, diagnosis and management of hypertension among patients on chronic dialysis. Nat Rev Nephrol 12:636–647

    Article  CAS  PubMed  Google Scholar 

  • Goldstein SL, Silverstein DM, Leung JC, Feig DI, Soletsky B, Knight C, Warady BA (2008) Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis. Pediatr Nephrol 23:129–135

    Article  PubMed  Google Scholar 

  • Ha IS, Yap HK, Munarriz RL, Zambrano PH, Flynn JT, Bilge I, Szczepanska M, Lai WM, Antonio ZL, Gulati A, Hooman N, van Hoeck K, Higuita LM, Verrina E, Klaus G, Fischbach M, Riyami MA, Sahpazova E, Sander A, Warady BA, Schaefer F, International Pediatric Peritoneal Dialysis Network Registry (2015) Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis. Kidney Int 88:605–613

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Halbach SM, Martz K, Mattoo T, Flynn J (2012) Predictors of blood pressure and its control in pediatric patients receiving dialysis. J Pediatr 160:621–625

    Article  PubMed  Google Scholar 

  • Hatch M, Freel RW, Vaziri ND (1998) Local upregulation of colonic angiotensin II receptors enhances potassium excretion in chronic renal failure. Am J Physiol 274(2 Pt 2):F275–F282

    CAS  PubMed  Google Scholar 

  • Heerspink HJ et al (2009) Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet 373:1009–1015

    Article  PubMed  PubMed Central  Google Scholar 

  • Inrig JK (2010) Antihypertensive agents in hemodialysis patients: a current perspective. Semin Dial 23:290–297

    Article  PubMed  PubMed Central  Google Scholar 

  • Jang JS, Kwon SK, Hy K (2011) Comparison of blood pressure control and left ventricular hypertrophy in patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). Electrolyte Blood Press 9:16–22

    Article  PubMed  PubMed Central  Google Scholar 

  • Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Brunet P (2011) Vascular incompetence in dialysis patients-protein-bound uremic toxins and endothelial dysfunction. Semin Dial 24:327–337

    Article  PubMed  Google Scholar 

  • Kayikcioglu M, Tumuklu M, Ozkahya M, Ozdogan O, Asci G, Duman S, Toz H, Can LH, Basci A, Ok E (2009) The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant 24:956–962

    Article  PubMed  Google Scholar 

  • Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ (2003) Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol. 14:425–430

    Article  CAS  PubMed  Google Scholar 

  • Knoll GA, Sahgal A, Nair RC, Graham J, van Walraven C, Burns KD (2002) Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients. Am J Med 112:110–114

    Article  CAS  PubMed  Google Scholar 

  • Kramer AM, van Stralen KJ, Jager KJ, Schaefer F, Verrina E, Seeman T, Lewis MA, Boehm M, Simonetti GD, Novljan G, Groothoff JW (2011) Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe. Kidney Int 80:1092–1098

    Article  PubMed  Google Scholar 

  • Krause I, Birk E, Davidovits M, Cleper R, Blieden L, Pinhas L, Gamzo Z, Eisenstein B (2001) Inferior vena cava diameter: a useful method for estimation of fluid status in children on haemodialysis. Nephrol Dial Transplant 16:1203–1206

    Article  CAS  PubMed  Google Scholar 

  • Lin JJ, Mitsnefes MM, Smoyer WE, Valentini RP (2009) Antihypertensive prescription in pediatric dialysis: a practitioner survey by the Midwest Pediatric Nephrology Consortium study. Hemodial Int 13:307–315

    Article  PubMed  Google Scholar 

  • Lin C, Zhang Q, Zhang H, Lin A (2016) Long-Term Effects of Low-Dose Spironolactone on Chronic Dialysis Patients: A Randomized Placebo-Controlled Study. J Clin Hypertens (Greenwich) 18:121–128

    Article  CAS  Google Scholar 

  • Lingens N, Soergel M, Loirat C, Busch C, Lemmer B, Schärer K (1995) Ambulatory blood pressure monitoring in paediatric patients treated by regular haemodialysis and peritoneal dialysis. Pediatr Nephrol 9:167–172

    Article  CAS  PubMed  Google Scholar 

  • London GM, Marchais SJ, Guerin AP, Metivier F, Safar ME, Fabiani F, Froment L (1990) Salt and water retention and calcium blockade in uremia. Circulation 82:105–113

    Article  CAS  PubMed  Google Scholar 

  • Maduell F, Navarro V (2000) Dietary salt intake and blood pressure controlin hemodialysis patients. Nephrol Dial Transplant 15:2063

    Article  CAS  PubMed  Google Scholar 

  • Martin RS, Panese S, Virginillo M, Gimenez M, Litardo M, Arrizurieta E, Hayslett JP (1986) Increased secretion of potassium in the rectum of humans with chronic renal failure. Am J Kidney Dis 8:105–110

    Article  CAS  PubMed  Google Scholar 

  • Matsumoto Y, Mori Y, Kageyama S, Arihara K, Sugiyama T, Ohmura H, Yakushigawa T, Sugiyama H, Shimada Y, Nojima Y, Shio N (2014) Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients. J Am Coll Cardiol 63:528–536

    Article  CAS  PubMed  Google Scholar 

  • Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243–1248

    Article  CAS  PubMed  Google Scholar 

  • Mitsnefes MM (2012) Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol 23:578–585

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF (2001) Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 16:318–323

    Article  CAS  PubMed  Google Scholar 

  • Mitsnefes MM, Barletta GM, Dresner IG, Chand DH, Geary D, Lin JJ, Patel H (2006) Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 21:1167–1170

    Article  PubMed  Google Scholar 

  • Mitsnefes MM, Laskin BL, Dahhou M, Zhang X, Foster BJ (2013) Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010. JAMA 309:1921–1929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moissl U, Arias-Guillén M, Wabel P, Fontseré N, Carrera M, Campistol JM, Maduell F (2013) Bioimpedance-guided fluid management in hemodialysis patients. Clin J Am Soc Nephrol 8:1575–1582

    Article  PubMed  PubMed Central  Google Scholar 

  • National Kidney Foundation (2005) K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45(4 suppl 3):S1–S153

    Google Scholar 

  • Onofriescu M, Hogas S, Voroneanu L, Apetrii M, Nistor I, Kanbay M, Covic AC (2014) Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis 64:111–118

    Article  PubMed  Google Scholar 

  • Patel HP, Goldstein SL, Mahan JD, Smith B, Fried CB, Currier H, Flynn JT (2007) A standard, noninvasive monitoring of hematocrit algorithm improves blood pressure control in pediatric hemodialysis patients. Clin J Am Soc Nephrol 2:252–257

    Article  PubMed  Google Scholar 

  • Peters CD, Kjaergaard KD, Jensen JD, Christensen KL, Strandhave C, Tietze IN, Novosel MK, Bibby BM, Jensen LT, Sloth E, Jespersen B (2014) No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patients. Kidney Int 86:625–637

    Article  CAS  PubMed  Google Scholar 

  • Pietilä-Effati PM, Salmela AK, Niemi RT, Ylitalo AS, Koistinen MJ (2016) Renal sympathetic denervation in treating drug-resistant hypertension in a patient on hemodialysis. J Hypertens 34:368–370

    Article  PubMed  Google Scholar 

  • Rahman M, Griffin V, Kumar A, Manzoor F, Wright JT Jr, Smith MC (2002) A comparison of standardized versus “usual” blood pressure measurements in hemodialysis patients. Am J Kidney Dis 39:1226–1230

    Article  PubMed  Google Scholar 

  • Sadowski RH, Allred EN, Jabs K (1993) Sodium modeling ameliorates intradialytic and interdialytic symptoms in young hemodialysis patients. J Am Soc Nephrol. 4:1192–1198

    CAS  PubMed  Google Scholar 

  • Sanghavi S, Whiting S, Uribarri J (2013) Potassium balance in dialysis patients. Semin Dial 26:597–603

    Article  PubMed  Google Scholar 

  • Scavarda VT, Pinheiro AC, Costa SD, de Andrade ZM, Carvalhaes JT, Campos O, Carvalho AC, Moises VA (2014) Children with chronic renal disease undergoing dialysis or conservative treatment-differences in structural and functional echocardiographic parameters. Echocardiography. 31:1131–1137

    Article  PubMed  Google Scholar 

  • Schaefer F, Doyon A, Azukaitis K, Bayazit A, Canpolat N, Duzova A, Niemirska A, Sözeri B, Thurn D, Anarat A, Ranchin B, Litwin M, Caliskan S, Candan C, Baskin E, Yilmaz E, Mir S, Kirchner M, Sander A, Haffner D, Melk A, Wühl E, Shroff R (2017) Querfeld U; 4C Study Consortium. Cardiovascular Phenotypes in Children with CKD: The 4C Study. Clin J Am Soc Nephrol 12:19–28

    Article  PubMed  Google Scholar 

  • Schmidt RJ, Domico J, Samsell LS, Yokota S, Tracy C, Sorkin MI et al (1999a) Indices of activity of the nitric oxide system in hemodialysis patients. Am J Kidney Dis 34:228–234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schmidt RJ, Yokota S, Tracy C, Sorkin MI, Baylis C (1999b) Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis. Am J Physiol 276:794–797

    Google Scholar 

  • Shafi T, Sozio SM, Luly J, Bandeen-Roche KJ, St Peter WL, Ephraim PL, McDermott A, Herzog CA, Crews DC, Scialla JJ, Tangri N, Miskulin DC, Michels WM, Jaar BG, Zager PG, Meyer KB, Wu AW (2017) Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators. Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices. Medicine (Baltimore) 96:e5924

    Google Scholar 

  • Shibasaki Y, Masaki H, Nishiue T, Nishikawa M, Matsubara H, Iwasaka T (2002) Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. Nephron 90:256–261

    Article  CAS  PubMed  Google Scholar 

  • Sinha MD, Tibby SM, Rasmussen P, Rawlins D, Turner C, Dalton RN, Reid CJ, Rigden SP, Booth CJ, Simpson JM (2011) Blood pressure control and left ventricular mass in children with chronic kidney disease. Clin J Am Soc Nephrol 543–551

    Google Scholar 

  • Song JH, Park GH, Lee SY, Lee SW, Lee SW, Kim MJ (2005) Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol 16:237–246

    Article  PubMed  Google Scholar 

  • Sorof JM (1999) Ambulatory blood pressure monitoring in pediatric end-stage renal disease: Chronic dialysis and transplantation. Blood Press Monit 4:171–174

    CAS  PubMed  Google Scholar 

  • Sorof JM, Brewer ED, Portmann RJ (1999) Ambulatory blood pressure monitoring and interdialytic weight gain in children receiving chronic hemodialysis. Am J Kidney Dis 33:667–674

    Article  CAS  PubMed  Google Scholar 

  • Thumfart J, Hilliger T, Stiny C, Wagner S, Querfeld U, Müller D (2015) Is peritoneal dialysis still an equal option? Results of the Berlin pediatric nocturnal dialysis program. Pediatr Nephrol 30:1181–1187

    Article  PubMed  Google Scholar 

  • Tkaczyk M, Nowicki M, Balasz-Chmielewska I, Boguszewska-Baczkowska H, Drozdz D, Kollataj B et al (2006) Hypertension in dialysed children: the prevalence and therapeutic approach in Poland-a nation wide survey. Nephrol Dial Transplant 21:736–742

    Article  PubMed  Google Scholar 

  • van Stralen KJ, Krischock L, Schaefer F, Verrina E, Groothoff JW, Evans J, Heaf J, Ivanov D, Kostic M, Maringhini S, Podracká L, Printza N, Pundziene B, Reusz GS, Vondrak K, Jager KJ, Tizard EJ, ESPN/ERA-EDTA Registry (2012) Prevalence and predictors of the sub-target Hb level in children on dialysis. Nephrol Dial Transplant 27:3950–3957

    Article  PubMed  Google Scholar 

  • Vujicić B, Mikolasević I, Racki S, Orlić L, Ljutić D, Bubić I (2013) BCM—body composition monitor: a new tool for the assessment of volume-dependent hypertension in patients on maintenance haemodialysis. Coll Antropol 37:815–819

    PubMed  Google Scholar 

  • Warren DJ, Ferris TF (1970) Renin secretion in renal hypertension. Lancet 1:159–162

    Article  CAS  PubMed  Google Scholar 

  • Wauters JP, Waeber B, Brunner HR, Guignard JP, Turini GA, Gavras H (1981) Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction. Clin Nephrol 16:86–92

    CAS  PubMed  Google Scholar 

  • Weir MA, Dixon SN, Fleet JL, Roberts MA, Hackam DG, Oliver MJ, Suri RS, Quinn RR, Ozair S, Beyea MM, Kitchlu A, Garg AX (2015) β-Blocker dialyzability and mortality in older patients receiving hemodialysis. J Am Soc Nephrol 26:987–996

    Article  CAS  PubMed  Google Scholar 

  • Wetmore JB, Mahnken JD, Phadnis MA, Ellerbeck EF, Shireman TI (2015) Relationship between calcium channel blocker class and mortality in dialysis. Pharmacoepidemiol Drug Saf 24:1249–1258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • White CM (1998) Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors. Pharmacotherapy 18:588–599

    CAS  PubMed  Google Scholar 

  • Wühl E, Fusch C, Schärer K, Mehls O, Schaefer F (1996) Assessment of total body water in paediatric patients on dialysis. Nephrol Dial Transplant 11:75–80

    Article  PubMed  Google Scholar 

  • Zaloszyc A, Schaefer B, Schaefer F, Krid S, Salomon R, Niaudet P, Schmitt CP, Fischbach M (2013) Hydration measurement by bioimpedance spectroscopy and blood pressure management in children on hemodialysis. Pediatr Nephrol 28:2169–2177

    Article  PubMed  Google Scholar 

  • Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent I, Pocock SJ, Pitt B, EMPHASIS-HF Study Group (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11–21

    Article  CAS  PubMed  Google Scholar 

  • Zazgornik J, Biesenbach G, Janko O, Gross C, Mair R, Brücke P, Debska-Slizien A, Rutkowski B (1998) Bilateral nephrectomy: the best, but often overlooked, treatment for refractory hypertension in hemodialysis patients. Am J Hypertens 11(11 Pt 1):1364–1370

    Article  CAS  PubMed  Google Scholar 

  • Zoccali C, Mallamaci F (2014) Pleiotropic effects of angiotensin II blockers in hemodialysis patients: myth or reality? Kidney Int 86:469–471

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Nephrology Center, Pediatrics and Adolescent Medicine, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany

    Franz Schaefer

Authors
  1. Franz Schaefer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Franz Schaefer .

Editor information

Editors and Affiliations

  1. Division of Nephrology, Seattle Children's Hospital, Seattle, Washington, USA

    Joseph Flynn

  2. Massachusetts General Hospital, Boston, Massachusetts, USA

    Julie R. Ingelfinger

  3. Arkansas Children's Hospital, University of Arkansas Medical Science, Little Rock, Arkansas, USA

    Karen Redwine

Section Editor information

  1. Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA

    Joseph T. Flynn MD, MS

  2. Division of Nephrology, Seattle Children’s Hospital, 4800 Sand Point Way, NE, 98105, Seattle, WA, USA

    Joseph T. Flynn MD, MS

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Schaefer, F. (2017). Hypertension in End-Stage Renal Disease: Dialysis. In: Flynn, J., Ingelfinger, J., Redwine, K. (eds) Pediatric Hypertension. Springer, Cham. https://doi.org/10.1007/978-3-319-31420-4_48-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31420-4_48-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31420-4

  • Online ISBN: 978-3-319-31420-4

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Hypertension in End-Stage Kidney Disease: Dialysis
    Published:
    20 January 2023

    DOI: https://doi.org/10.1007/978-3-319-31420-4_48-3

  2. Hypertension in End-Stage Renal Disease: Dialysis
    Published:
    05 August 2022

    DOI: https://doi.org/10.1007/978-3-319-31420-4_48-2

  3. Original

    Hypertension in End-Stage Renal Disease: Dialysis
    Published:
    20 April 2017

    DOI: https://doi.org/10.1007/978-3-319-31420-4_48-1

Search

Navigation